Opportunity Information: Apply for PAR 11 102
Apply for PAR 11 102
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Pre Application for the 2011 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (X02)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Feb 3, 2011 and posted on Feb 3, 2011.
- Applicants must submit their applications by Mar 17, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: City or township governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments State governments Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses Native American tribal organizations (other than Federally recognized tribal governments) County governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Independent school districts.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Pre-Application for the 2011 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (X02)" (Funding Opportunity Number PAR 11-102) is a National Institutes of Health (NIH) funding announcement issued through the National Institute on Drug Abuse (NIDA). It is a discretionary grant mechanism using the X02 activity code, which in this context functions as a pre-application step. The main aim is to invite and encourage prospective applicants to submit pre-applications that outline a strong, credible vision for translating research findings into real-world medications that can treat diseases of addiction. Rather than simply supporting basic discovery science, this program emphasizes the path from discovery to therapeutics, focusing on researchers who are positioned to move ideas toward tangible medication development.
At its core, the Translational Avant Garde Award is intended for dedicated and highly capable basic and/or clinical investigators who have the expertise, motivation, and long-term commitment needed to push promising scientific insights toward safe and effective treatments. NIDA frames the program as a way to accelerate meaningful advances in medication development for substance use disorders, explicitly calling out disorders related to tobacco, cannabis, cocaine, methamphetamine, heroin, and prescription opiate use or abuse. In other words, the opportunity is targeted at translational medication development efforts that could ultimately reduce addiction-related harm by expanding the range of evidence-based pharmacologic treatment options.
The funding announcement sits within the broader NIH mission area of health and is associated with CFDA number 93.279, "Drug Abuse and Addiction Research Programs." It does not require cost sharing or matching, which can lower barriers for applicants by allowing project proposals to be judged primarily on scientific and translational merit rather than an applicant's ability to contribute non-federal funds.
Eligibility is broad and includes many types of organizations that commonly participate in NIH research and public health funding. Eligible applicants include state governments, county and city or township governments, special district governments, and independent school districts. Academic applicants may include public and state-controlled institutions of higher education as well as private institutions of higher education. The announcement also allows applications from nonprofits both with and without 501(c)(3) status (excluding universities in those specific nonprofit categories), public housing authorities and Indian housing authorities, and for-profit organizations other than small businesses, alongside small businesses themselves. In addition, NIDA/NIH explicitly recognizes additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based and community-based organizations, regional organizations, U.S. territories or possessions, and certain tribal entities (including federally recognized tribal governments and other tribal governments). The eligibility list also extends to eligible federal agencies and even non-U.S. entities (foreign organizations), indicating an intent to draw from a wide pool of translational expertise and infrastructure when it aligns with the program goals.
Key dates reflect a single-cycle window for this pre-application solicitation. The opportunity was posted and created on February 3, 2011, with an original and current closing date of March 17, 2011, and an archive date of April 17, 2011. Practically speaking, that timeline signals that applicants needed to move quickly to prepare a pre-application package that clearly communicated the translational concept, the scientific premise, and the investigator's ability to drive medication development efforts forward.
For applicants or institutions trying to access the full announcement, NIH provided an official additional information link to the NIH grants guide page for PAR 11-102. Technical support contacts were also provided through the NIH Office of Extramural Research (OER) webmaster email addresses for issues accessing or linking to the announcement. Overall, the opportunity is best understood as an NIH/NIDA invitation to enter a competitive pipeline aimed at speeding the development of medications for major addiction-related disorders by identifying investigators with standout translational ideas and the capability to pursue them.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Pre-Application for the 2011 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (X02)."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is PAR 11-102.
Which agency is offering this opportunity?
This is a National Institutes of Health (NIH) funding announcement issued through the National Institute on Drug Abuse (NIDA).
What is the purpose of this opportunity?
The purpose is to invite and encourage prospective applicants to submit pre-applications that present a strong, credible vision for translating research findings into real-world medications to treat diseases of addiction.
Is this opportunity focused on basic research or translation to therapeutics?
It emphasizes translation from discovery to therapeutics. Rather than primarily supporting basic discovery science, it focuses on moving ideas toward tangible medication development.
What activity code is used, and what does it mean here?
The activity code is X02. In this context, it functions as a pre-application step (a discretionary grant mechanism used to support the pre-application process for this program).
Who is this program intended for?
It is intended for dedicated and highly capable basic and/or clinical investigators with the expertise, motivation, and long-term commitment to advance promising insights toward safe and effective treatments.
What problem area does the program target?
The program targets medication development for diseases of addiction, aiming to accelerate meaningful advances in pharmacologic treatment options for substance use disorders.
Which substance use disorders are explicitly called out?
The announcement explicitly calls out disorders related to tobacco, cannabis, cocaine, methamphetamine, heroin, and prescription opiate use or abuse.
What is the broader NIH mission area for this funding announcement?
It sits within the NIH mission area of health and is associated with drug abuse and addiction research programming.
What CFDA number is associated with this opportunity?
The CFDA number is 93.279, "Drug Abuse and Addiction Research Programs."
Is cost sharing or matching required?
No. The announcement states that cost sharing or matching is not required.
What types of organizations are eligible to apply?
Eligibility is broad and includes many organization types, including government entities, academic institutions, nonprofits, for-profits, small businesses, certain tribal entities, eligible federal agencies, and foreign organizations (non-U.S. entities), among others listed in the announcement.
Are state and local government entities eligible?
Yes. Eligible applicants include state governments, county governments, city or township governments, special district governments, and independent school districts.
Are colleges and universities eligible?
Yes. Eligible academic applicants include public and state-controlled institutions of higher education as well as private institutions of higher education.
Are nonprofit organizations eligible?
Yes. Nonprofits with and without 501(c)(3) status are eligible, as described in the announcement (with specific exclusions noted for universities within those nonprofit categories).
Are for-profit organizations eligible?
Yes. For-profit organizations other than small businesses are eligible, and small businesses are also eligible.
Are public housing authorities eligible?
Yes. Public housing authorities and Indian housing authorities are included among eligible applicants.
Are Historically Black Colleges and Universities (HBCUs) eligible?
Yes. HBCUs are explicitly recognized as eligible applicant organizations.
Are Hispanic-serving institutions eligible?
Yes. Hispanic-serving institutions are explicitly recognized as eligible.
Are Tribally Controlled Colleges and Universities (TCCUs) eligible?
Yes. TCCUs are explicitly recognized as eligible.
Are Alaska Native and Native Hawaiian Serving Institutions eligible?
Yes. Alaska Native and Native Hawaiian Serving Institutions are explicitly recognized as eligible.
Are faith-based and community-based organizations eligible?
Yes. Faith-based and community-based organizations are explicitly recognized as eligible.
Are regional organizations eligible?
Yes. Regional organizations are included among the recognized eligible applicant categories.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are included in the eligibility list.
Are tribal governments eligible?
Yes. The eligibility list includes federally recognized tribal governments as well as other tribal governments.
Are federal agencies eligible to apply?
Yes. Eligible federal agencies are included in the eligibility list.
Are foreign (non-U.S.) organizations eligible?
Yes. The announcement indicates that non-U.S. entities (foreign organizations) are eligible.
When was this funding opportunity posted?
The opportunity was posted (created) on February 3, 2011.
What was the application closing date?
The original and current closing date listed is March 17, 2011.
When was the archive date?
The archive date is April 17, 2011.
Does this appear to be a single-cycle pre-application window?
Yes. The dates provided reflect a single-cycle window for the pre-application solicitation, with the posted date in early February 2011 and a mid-March 2011 closing date.
Where can applicants find the official full announcement?
NIH provided an official additional information link to the NIH grants guide page for PAR 11-102.
Who is listed for technical support if there are access or link issues?
Technical support contacts were provided through the NIH Office of Extramural Research (OER) webmaster email addresses for issues accessing or linking to the announcement.
In plain terms, what is NIDA trying to accomplish with this program?
NIDA is aiming to speed the development of medications for major addiction-related disorders by identifying investigators with standout translational ideas and the capability to move those ideas toward real-world medication development.
Browse more opportunities from the same category: Education Health
Next opportunity: 2011 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (DP1)
Previous opportunity: OVW Fiscal Year 2011 Transitional Housing Assistance Program Grants for Victims of Sexual Assault, Domestic Violence, Dating Violence and Stalking
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 11 102
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 11 102) also looked into and applied for these:
| Funding Opportunity |
|---|
| 2011 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (DP1) Apply for RFA DA 11 009 Funding Number: RFA DA 11 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44) Apply for RFA CA 11 002 Funding Number: RFA CA 11 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Predictive Animal Models for Smoking Cessation Medications (U54) Apply for RFA DA 11 014 Funding Number: RFA DA 11 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Centers for AIDS Research and Developmental Centers for AIDS Research (P30) Apply for PAR 11 108 Funding Number: PAR 11 108 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Grand Opportunity in Medications Development for Substance Related Disorders (U01) Apply for PAR 11 109 Funding Number: PAR 11 109 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (Parent F31) Apply for PA 11 111 Funding Number: PA 11 111 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NINR Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows In Nursing Research (F31) Apply for PAR 11 117 Funding Number: PAR 11 117 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Specific pathogen free macaque colonies (U42) Apply for PAR 11 116 Funding Number: PAR 11 116 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Specific pathogen free macaque colonies (U24) Apply for PAR 11 115 Funding Number: PAR 11 115 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV/AIDS Implementation Science Targeting Drug Using Populations A Collaboration with PEPFAR (R01) Apply for RFA DA 12 002 Funding Number: RFA DA 12 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Placebo Effect Mechanisms and Methodology (R21) Apply for RFA DA 12 004 Funding Number: RFA DA 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Placebo Effect Mechanisms and Methodology (R01) Apply for RFA DA 12 003 Funding Number: RFA DA 12 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Childhood Cancer Survivor Study (CCSS)(Limited Competition U24) Apply for RFA CA 11 501 Funding Number: RFA CA 11 501 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medication Initiative for Tobacco Dependence (MITD) A New Product Development Partnership (PDP)(UH2/UH3) Apply for RFA DA 11 015 Funding Number: RFA DA 11 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Centers in Minority Institutions Program (G12) Apply for PAR 11 132 Funding Number: PAR 11 132 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NLM Institutional Training Grants for Research Training in Biomedical Informatics (T 15) Apply for RFA LM 11 001 Funding Number: RFA LM 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition National Primate Research Centers (P51) Apply for PAR 11 136 Funding Number: PAR 11 136 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Development and Translation of Medical Technologies to Reduce Health Disparities (R43/R44) Apply for RFA EB 11 001 Funding Number: RFA EB 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) Apply for PAR 11 150 Funding Number: PAR 11 150 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Strategic Partnering to Evaluate Cancer Signatures SPECS II (U01) Apply for PAR 11 151 Funding Number: PAR 11 151 Agency: National Institutes of Health Category: Education Health Funding Amount: $680,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 11 102", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.